“…Structural imaging such as computer tomography (CT) and conventional MRI (T1‐weighted and T2‐weighted) have essentially been inefficient to help with the diagnosis of mTBI. Other neuroimaging methods such as functional MRI (task‐based MRI and resting state MRI; e.g., Chen, Johnston, Collie, McCrory, & Ptito, 2007; Mayer et al, 2015), diffusion weighted imaging (DWI) (Shenton, Price, Levin, & Edersheim, 2018), susceptibility weighted imaging (SWI; Lu, Cao, Wei, Li, & Li, 2015; Studerus‐Germann, Thiran, Daducci, & Gautschi, 2016), perfusion weighted imaging (PWI; Andre, 2015; Hamer, Churchill, Hutchison, Graham, & Schweizer, 2020; Clark et al, 2020), positron emission tomography (PET) (Jensen & Lauritzen, 2019; Raji & Henderson, 2018), and single photon emission computed tomography (SPECT) (Amen et al, 2016; Romero, Lobaugh, Black, Ehrlich, & Feinstein, 2015) have shown promise, but even then the results have been mixed with a more common utilization in the research environment and a slower integration in the clinical setting due to cost and a lack of a standardization of the procedures.…”